HomeOwner SearchCategory Search
Visit USCOQuizartinib (AC220) Reverses ABCG2 and ABCB1-Medidated Multidrug Resistance (MDR)
Text Registration
Copyright Title
Quizartinib (AC220) Reverses ABCG2 and ABCB1-Medidated Multidrug Resistance (MDR)
Status
Published
on 7 Nov 2014
Year of Creation
2014
Copyright Claimant
Priyank Kumar
Registration Number
TX0007867389
on 7 Nov 2014Copyright Summary
The U.S. Copyright record (Registration Number: TX0007867389) dated 7 Nov 2014, pertains to an electronic file (eService) titled "Quizartinib (AC220) Reverses ABCG2 and ABCB1-Medidated Multidrug Resistance (MDR)" created in 2014. The copyright holder is Priyank Kumar, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Priyank Kumar.
Application Details
Registration Number
TX0007867389
Registration Date
11/7/2014
Year of Creation
2014
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Computer text data
Notes
Rights Note: Rights and permissions info. on CORDS appl. in CO
Local Copyright Note: Electronic registration
Statements
Author Statement: entire text: Priyank Kumar
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.